In the context of Meaningful Use, the Center for Medicaid and Medicare Services defines CQMs as follows on www.cms.gov:



Similar documents
Use Case Summary NAME OF UC: SINGLE SIGN ON FOR HEALTHCARE PROVIDERS AND PATIENTS. Sponsor(s): Michigan Department of Health and Human Services

SINGLE SIGN ON FOR HEALTHCARE PROVIDERS AND CONSUMERS

An Open Source Meaningful Use Stage 2 Clinical Quality Measure Testing and Certification Tool

Medicare & Medicaid EHR Incentive Programs

An Open Source Clinical Quality Measure Testing and Certification Tool

Open Source Software Tools for Electronic Clinical Quality Measures

Summary of Public Health Related Aspects of Recent ONC and CMS Final Rules Version 1.0

Medicare & Medicaid EHR Incentive Programs- Past, Present, & Future. Travis Broome, Centers for Medicare & Medicaid Services 12/18/2012

HIMSS Public Policy Initiatives in 2015: Using Health IT to Enable Healthcare Transformation Jeff Coughlin Senior Director Federal & State Affairs

Minnesota EHR Incentive Program (MEIP) Program Year Timeline for EPs, EHs and CAHs. Updated November 2015

Overview of MU Stage 2 Joel White, Health IT Now

The Road to Robust Use of HIT: Navigating Meaningful Use and Beyond. by Jennifer McAnally, tnrec Director

Agenda. Overview of Stage 2 Final Rule Impact to Program

Stage 2 Overview Tipsheet Last Updated: August, 2012

Meaningful Use: Stage 1 and 2 Hospitals (EH) and Providers (EP) Lindsey Mongold, MHA HIT Practice Advisor Oklahoma Foundation for Medical Quality

STAGE 2 of the EHR Incentive Programs

CCO Incentive Metrics: Requirements for Reporting on EHR- Based Measures in 2015 GUIDANCE DOCUMENTATION

Meaningful Use Updates Stage 2 and 3. Julia Moore, Business Analyst SMC Partners, LLC July 8, 2015

Stage 2 Medical Billing and reconciliation of Patients

Health IT Enabled Quality Measurement and Improvement: The HL7 Clinical Quality Information Workgroup

Modifications to the Medicare and Medicaid Electronic Health Record (EHR) Incentive Program for 2014 Final Rule Summary

Michigan Medicaid EHR Incentive Program. Ryan Koolen - MDCH

TABLE 1: STAGE OF MEANINGFUL USE CRITERIA BY FIRST PAYMENT YEAR

The HITECH Act and Meaningful Use Implications for Population and Public Health

Impact of Meaningful Use and Healthcare Transformation On Patient Access

Meaningful Use Stage 2 Administrator Training

Reporting Once for 2014 Medicare Quality Reporting Programs

Best Practices and Lessons Learned about EHR Adoption. Anthony Rodgers Deputy Administrator, Center for Strategic Planning

Hospital Inpatient Quality Reporting Requirements

Welcome to the Data Analytics Toolkit PowerPoint presentation on clinical quality measures, meaningful use, and data analytics.

11/7/2013 HARMONIZING & STANDARDIZING BEHAVIORAL HEALTH CLAIMS, DATA COLLECTION AND REPORTING REQUIREMENTS. Xpio Health. MITA 3.

Agenda. What is Meaningful Use? Stage 2 - Meaningful Use Core Set. Stage 2 - Menu Set. Clinical Quality Measures (CQM) Clinical Considerations

The Meaning Behind Meaningful Use Stage 2

Stage 2 Meaningful Use What the Future Holds. Lindsey Wiley, MHA HIT Manager Oklahoma Foundation for Medical Quality

Eligible Professionals (EPs) Purdue Research Foundation

Michigan Medicaid EHR Incentive Program Update November 28, Jason Werner, MDCH

Physician Quality Reporting System (PQRS) Qualified Clinical Data Registry (QCDR) QCDR Reporting Overview. Program Year 2014

ARRA HITECH Meaningful Use Objectives & Implications to Public Health Lab

EHR Incentive Programs

Making Meaningful Use Reports Meaningful

Meaningful Use Qualification Plan

NQF health information technology glossary. a guide to HIT jargon

Quality Reporting Under Meaningful Use Stage 2. Crystal Kallem, Director of Business Analysis & Policy Lantana Consulting Group

MEANINGFUL USE STAGE 3 AND CERTIFICATION PROPOSED RULES

The CMS EHR Incentive Programs: Small-Practice Providers and Clinical Quality Measures

LOOKING FORWARD TO STAGE 2 MEANINGFUL USE Louisiana HIPAA & EHR Conference Presenter: Kathleen Keeley

Meaningful Use: Terms & Timelines, Changes to Stage 1, and Stage 2 Overview

Who are we? *Founded in 2005 by Purdue University, the Regenstrief Center for Healthcare Engineering, and the Indiana Hospital Association.

Michigan Medicaid EHR Incentive Program Update Jason Werner - MDCH

4Medapproved Learning Lunch Webinar Series How to Keep up with Stage 2 MU (Meaningful Use) Questions and Answers

Anthony Rodgers Deputy Administrator Centers for Innovation and Strategic Planning

November 22, Dear Ms. Tavenner:

Medicaid EHR Incentive Program Dentists as Eligible Professionals. Kim Davis-Allen, Outreach Coordinator

Centers for Medicare & Medicaid Services Quality Measurement and Program Alignment

Regulations Overview

How to Play by the (Final) Rules:

May 7, Dear Dr. Mostashari:

The Meaningful Use Stage 2 Final Rule: Overview and Outlook

Re: CMS 3323 NC, Request for Information (RFI): Certification Frequency and Requirements for the Reporting of Quality Measures Under CMS Programs

Meaningful Use 2015 and beyond. Presented by: Anna Mrvelj EMR Training Specialist

Eligible Hospitals Meaningful Use Stage 1

Meaningful Use. Medicare and Medicaid EHR Incentive Programs

Meaningful Use Stage 2 MU Audits

Meaningful Use Stage 2 Requirements Primer

Electronic Health Record (EHR) Incentive Program. Meaningful Use Frequently Asked Questions Webinar

IMS Meaningful Use Webinar

Reporting Period: For Stage 2, the reporting period must be the entire Federal Fiscal Year.

Summary of the Proposed Rule for the Medicare and Medicaid Electronic Health Records (EHR) Incentive Program (Eligible Professionals only)

Stage 2 Final Rule Overview: Updates to Stage 1 and New Stage 2 Requirements

Meaningful Use Stage 2: What s Next?

Three Proposed Rules on EHRs:

Demonstrating Meaningful Use of EHRs: The top 10 compliance challenges for Stage 1 and what s new with 2

= AUDIO 8/20/2015. e Clinical Quality Reporting for Hospitals and Providers. An Important Reminder. Mission of OFMQ. Ashley Rhude RHIA, CHTS IM

T he Health Information Technology for Economic

Meaningful Use Stage 2:

STAGES 1 AND 2 REQUIREMENTS FOR MEETING MEANINGFUL USE OF EHRs 1

HL7 Quality Reporting Document Architecture. standardized quality reports

Meaningful Use Stage 2. Meeting Meaningful Use Stage 2 with InstantPHR TM.

EHR Incentive Program Focus on Stage One Meaningful Use. Kim Davis-Allen, Outreach Coordinator October 16, 2014

Meaningful Use in 2015 and Beyond Changes for Stage 2

Understanding Meaningful Use Stage 2

State Medicaid EHR Incentives and Strategic Developments

Meaningful Use Stage 2

Electronic Health Record Incentive Program Update May 29, Florida Health Information Exchange Coordinating Committee

Meaningful Use EHR Incentive Program

Meaningful Use 2014: Stage 2 MU Overview. Scott A. Jens, OD, FAAO October 16, 2013

Leveraging the Provider Incentive Program for Increased Functionality Beyond Meaningful Use

NHCHC Meaningful Use of Electronic Health Records Resource Catalogue. Meaningful Use Overview

Meaningful Use Madness: Stage 3 Overview APRIL 08, 2015

Electronic Health Record (EHR) Incentive Program. Stage 2 Final Rule Update

Medicaid EHR Incentive Program. Focus on Stage 2. Kim Davis-Allen, Outreach Coordinator

MEANINGFUL USE Stages 1 & 2

9/9/2015. Medicare/Medicaid Incentive Program. Medicare/Medicaid Incentive Program. Meaningful Use, Penalties and Audits

Alabama s One Health Record

Stage 2 Meaningful Use

Collaborating to Meet the Challenge of PQRS EHR-Based Reporting

Medicare & Medicaid EHR Incentive Programs

May 7, Re: RIN 0991-AB82. Dear Secretary Sebelius:

Aligning Meaningful Use CQM and PQRS Reporting for 2015

Six Steps to Achieving Meaningful Use Qualification, Stage 1

Transcription:

Use Case Summary NAME OF UC: EXCHANGE/ACCESS CLINICAL QUALITY MEASURES Sponsor(s): Jason Werner, MDHHS Date: 9/22/15 The purpose of this Use Case Summary is to allow Sponsors, Participants, and other readers to understand the purpose of the Use Case (UC), the value proposition the UC represents, and what the Use Case does, requires, and how the UC operates at a high level. The summary is intended to assist the HIE and HIT Community in understanding where this UC fits within the overall roadmap for statewide sharing of health information. This UC Summary has several sections allowing readers to understand the impact of this UC in the following areas: health outcomes, regulation, cost and revenue, implementation challenges, vendor community, and support. Executive Summary In this section provide a brief (3 5 sentence) summary of the UC s function and purpose. Also include a brief description of the importance and highlight the expected positive impact from implementation of this UC. Clinical Quality Measures (CQMs) are measures of healthcare quality generated in a clinical setting by using clinically gathered information such as lab results, vital signs, symptoms, x rays, etc. CQMs, properly utilized, can help transform healthcare delivery to improve care for patients and help transform healthcare payment to be quality based instead of volume based. In the context of Meaningful Use, the Center for Medicaid and Medicare Services defines CQMs as follows on www.cms.gov: Clinical quality measures, or CQMs, are tools that help us measure and track the quality of healthcare services provided by eligible professionals (EPs), eligible hospitals (EHs) and critical access hospitals (CAHs) within our healthcare system. These measures use a wide variety of data that are associated with a provider s ability to deliver high quality care or relate to long term goals for healthcare quality. CQMs measure many aspects of patient care including: health outcomes, clinical processes, patient safety, efficient use of healthcare resources, care coordination, patient engagements, population and public health, and clinical guidelines. Reporting certain CQMs is a requirement for Meaningful Use for both Medicaid and Medicare Electronic Health Record (EHR) Incentive Programs. 1

It is important to note that the productive use of CQMs is not limited to Medicaid and Medicare providers such as Eligible Professionals (EPs), Eligible Hospitals (EHs), and Critical Access Hospitals (CAHs). CQMs can and should be used above and beyond the Meaningful Use context. Any healthcare provider can improve patient care first by monitoring CQMs for their patients and for their organization and by then acting to improve the measures for their patient population by taking advantage of the feedback loop generated by continuous inspection of its CQMs by an organization. Purpose of Use Case: This Use Case enables providers to submit Clinical Quality Measures electronically, whether for Medicaid and MU attestation, or for non Medicaid providers wishing to take advantage of CQMs for Clinical Quality Improvement. This Use Case also enables State Medicaid to receive electronic Clinical Quality Measures submitted by Medicaid providers. Finally, this Use Case enables submitters, receivers, and other concerned parties such as Medicaid or Commercial Health Plans to access and view electronic Clinical Quality Measures across their provider spectrum. The widespread use of electronic Clinical Quality Measures is transformational for healthcare not simply because of Meaningful Use but because of the better outcomes that will result from the continuous process improvement (CPI) feedback loop that CQMs can drive in clinics, sometimes referred to as clinical quality improvement (CQI). CQMs are also needed at the national level for reporting and strategy, including determining where to apply resources. In a September 2012 presentation entitled The Future of Quality Measurement [Mostashari, Clancy, and Conway] the presenters put forth The National Quality Strategy outlining three interrelated National Quality Aims: Better Health for the Population Better Care for Individuals Lower Cost Through Improvement Figure 1 National Quality Aims: 2012 presentation by Mostashari, Clancy, and Conway The same 2012 joint presentation from ONC, CMS, and the Agency for Healthcare Research and Quality (AHRQ) outlined priorities related to achieving the National Quality Aims: 1) Making care safer by reducing harm caused in the delivery of care 2) Ensuring that each person and family are engaged as partners in their care 3) Promoting effective communication and coordination of care 4) Promoting the most effective prevention and treatment practices for the leading causes of mortality, starting with cardiovascular disease 2

5) Working with communities to promote wide use of best practices to enable healthy living 6) Making quality care more affordable for individuals, families, employers, and governments by developing and spreading new healthcare delivery models CQMs can play a role in the support of each of the three National Quality Aims and in all six priorities related to achieving the aims of better care, lower cost, and better health. Additionally, CQMs are an essential ingredient in the creation of a widespread Learning Health System. [C. P. Friedman, A. K. Wong, D. Blumenthal, Achieving a Nationwide Learning Health System. Sci. Transl. Med. 2, 57cm29 (2010)]. Electronic Clinical Quality Measures, called ecqms, are Clinical Quality Measures that are electronically captured or calculated locally in a clinical setting, such as in the clinic s Electronic Health Record (EHR) system, and then potentially transported electronically and securely to a centralized repository for analysis and comparison with other clinics. HHS and the National Quality Forum (NQF) have defined ecqms as: To further enable electronic measurement of EHR data, the NQF, under contract with the U.S. Department of Health and Human Services (HHS), supported the development of a Health Level Seven (HL7) standard known as the Health Quality Measures Format (HQMF) for representing a health quality measure as an electronic Extensible Markup Language (XML) document. A health quality measure encoded in HQMF is referred to as an emeasure or ecqm (electronic clinical quality measure). Through standardization of a measure s structure, metadata, definitions, and logic, the HQMF provides for quality measure consistency and unambiguous interpretation. HQMF is a component of a larger quality endto end framework in which providers will ideally be able to push a button and import these emeasures into their EHRs. The emeasures can be turned into queries that automatically query the EHR's data repositories and generate reports for quality reporting. From there, individual and/or aggregate patient quality data can be transmitted to the appropriate agency. There are four key attributes of electronic Clinical Quality Measures (ecqms) that set them apart and highlight their critical importance to improving outcomes in healthcare: 1. ecqms are generated by measuring actual clinical data, not from payer/claims data. The clinically derived measures come directly from clinical lab results, vital signs, etc. The type of quality measures that can be derived from clinical data cannot be generated from claims data. 2. ecqms enable healthcare providers to have and use their own tools for real time (or near real time) tracking of changes to their practice. ecqms act as a monitoring and feedback system to help providers to identify the need for and to effect changes that improve outcomes. For example, by monitoring their own clinical quality measures throughout the day, providers can identify care gaps within a care team the same day and close care gaps, potentially even while a patient is still present in the clinic. 3. Payers, not just providers, will benefit tremendously also, as ecqms represent a faster, less expensive way to generate quality measures. A study by Kaiser Permanente revealed that 3

clinical quality measures can save up to 50% over chart abstraction. So that the healthcare industry can move to truly value based purchasing and value based care, ecqms can give better clinical outcome information at lower cost and are more effective at driving change because they are real time and locally owned by the providers. 4. As we move to consumer directed and patient centered care, patient reported outcomes work well with ecqms but it is unclear whether claims based measures can support this. Overview In this section provide a more detailed explanation of the UC s function and purpose. The Exchange/Access Clinical Quality Measures Use Case enables any healthcare professional or organization to send CQMs through MiHIN to any Trusted Data Sharing Organization (TDSO) authorized to receive or access quality measure information for that professional or organization. The TDSO receiving the CQMs can then use them to create and view reports and dashboards such as cross clinical and intra clinical comparisons and other displays of trends and patterns in clinical quality to identify opportunities for improvement that can lead to better delivery and quality based payment. For example, the Michigan Department of Health and Human Services (MDHHS) is a TDSO which operates State Medicaid. Medicaid providers (EPs, EHs, and CAHs) must report CQMs to State Medicaid for the Meaningful Use (MU) Stage 2 credit instead of reporting to CMS. The Exchange/Access Clinical Quality Measures Use Case enables any Medicaid Eligible Professional (EP), Eligible Hospital (EH), or Critical Access Hospital (CAH) to send CQMs through MiHIN to MDHHS to receive MU Stage 2 attestation credit from State Medicaid. State Medicaid can then access the electronic CQMs to view reports, dashboards, comparisons, and so forth. Meaningful Use Attestation For quality measures submitted for MU attestation credit, CMS requires Medicaid providers to submit CQM data from a certified Electronic Health Record (EHR) to participate in the Medicare and Medicaid EHR Incentive Programs and receive incentive payments. MU Stage 2 requires submission of CQM files and specifies the criteria that an EP, EH or CAH must meet to attest to this MU requirement. 1 1 For more information visit: http://www.cms.gov/regulations and Guidance/Legislation/EHRIncentivePrograms/index.html http://www.cms.gov/regulations and Guidance/Legislation/EHRIncentivePrograms/ClinicalQualityMeasures.html 3 For more information visit: 4

CMS and HL7 have defined two different types of Quality Reporting Data Architecture (QRDA) files that are acceptable for Meaningful Use submission. These two types of QRDA files are referred to as Category 1 and Category 3 files. QRDA files facilitate communication of clinical information between senders and recipients of quality measurement data. QRDAs contain CQM data in standard formats that can be automatically generated by certified EHRs and consumed and processed by recipient databases. Both QRDA Category 1 (CAT 1) and QRDA Category 3 (CAT 3) files are in XML format. A QRDA CAT 1 file contains individual patient information including both Personal Identification Information (PII) and Protected Health Information (PHI), whereas a QRDA CAT 3 file contains aggregated individual patient data from QRDA CAT 1 files for a single National Provider Identifier (NPI) number for a reporting period, and thus has no PII or PHI. 2 Eligible Professionals, Eligible Hospitals and Critical Access Hospitals can send either QRDA CAT 1 or QRDA CAT 3 files to State Medicaid by sending them directly to MiHIN via Direct Secure Messaging (DSM) or through a TDSO connected to MiHIN. Inbound CQM messages received by MiHIN are validated and stored in a Data Mart and, if from Medicaid providers (EPs, EHs, and CAHs), the CQMs are sent to State Medicaid for storage and reporting via the State s data warehouse. Additional Uses Any provider, payer/health plan or health system, including non Medicaid providers, can participate in this Use Case to exchange and access CQMs to improve clinical quality. Healthcare providers, health systems or payers taking advantage of this opportunity may access reports and dashboards for only their associated quality measures. In the future, a Report Once capability can send copies of CQMs to the CMS Physicians Quality Reporting System (PQRS) avoiding the need to report CQMs twice at both the state and federal levels, particularly for hospitals. Reporting tools can access the Data Mart using different views, dashboards and permissions for a variety of possible audiences including but not limited to: State Medicaid (MDHHS) for MU2 CMS PQRS Provider/Clinical/Health System staff (e.g. Care Coordinators) Health Plan/Payer staff Medicaid Beneficiaries Other states http://www.cms.gov/regulations and Guidance/Legislation/EHRIncentivePrograms/Downloads/Guide_QRDA_2014eCQM.pdf 5

Diagram In this section, provide a diagram of the information flow for this UC. The diagram should include the major senders and receivers involved and types of information being shared. Primary Use: Additional Use: x 6

Regulation In this section, describe whether this UC is being developed in response to a federal regulation, state legislation or state level administrative rule or directive. Please reference the precise regulation, legislation, or administrative act such as Public Law 111 152 (Affordable Care Act), Public Law 111 5; Section 4104 (Meaningful Use), 42 CFR 2 (substance information), MCL 333.5431 (Newborn Screening), PA 129 (standard consent form), etc. Additionally, provide information if this UC will allow Eligible Professionals/Providers (EP) or Eligible Hospitals (EH) to meet an attestation requirement for Meaningful Use. Legislation/Administrative Rule/Directive Yes No Unknown Public Law 111 152 (Affordable Care Act) Public Law 111 5; Section 4104 (Meaningful Use) Meaningful Use: Yes No Unknown Cost and Revenue In this section provide an estimate of the investment of time and money needed or currently secured for this UC. Be sure to address items such as payer incentives, provide incentives, revenues generated (e.g. SSA transaction payments) or cost savings that could be realized (i.e. reduction of administrative burden). As information is known or available, provide information on the resources and infrastructure needed to move this UC into production. Costs: There are two types of costs for this Use Case. First is the cost to develop and implement the Use Case and to foster adoption. Costs for supporting quality measure submission are evolving as additional requirements are communicated for new phases of Meaningful Use attestation. Medicaid providers can receive 7

incentives for Meaningful Use by participating in this Use Case, to help pay for their investment of time and money to generate and submit CQMs. For MiHIN s development of this Use Case, initially grant funding from the Office of the National Coordinator on Health Information Technology (ONC) was used to develop the basic infrastructure. Additional funding from CMS and the State of Michigan is contributing to expansion of the infrastructure for CQM reporting and is also paying for the implementation and rollout of this Use Case for State Medicaid. EHR vendors, providers, and Health Information Exchanges (HIEs) are still building capabilities and workflows to begin submitting CQMs to State Medicaid by April 2016. In fiscal year 2014 MiHIN funded several early adopters to begin sending CQMs through directed integration projects using CMS/MDHHS funding budgeted for that purpose. Limited additional funding through MiHIN is available at least through 2017. The second cost related to this Use Case is the cost of not transforming to quality based delivery and payment in healthcare. It is widely recognized that the present volume based systems of delivery and payment are not sustainable and must change. Because CQMs are designed around activities that are associated with improved outcomes and reduced costs, their use over time should equate to demonstrable savings to both payers and care providers savings of time, money, and reduced utilization. Revenue: Because this Use Case is mandated by legislation and MU Stage 2, there is no charge to Medicaid providers to utilize this Use Case to submit quality measures for MU attestation credit for participants in Michigan. A modest fee structure may be implemented for participants wishing to submit quality measures for reasons other than MU attestation credit, for organizations in other states choosing to utilize this Use Case and service, or for participants wishing to access quality measures for their own quality improvement efforts. This fee structure will be factored such that it pays for the costs of operating the Use Case. 8

Implementation Challenges In this section, as information is known or available, describe challenges that may be faced to implement this UC. Be sure to address whether the UC leverages existing infrastructure, policies and procedures, ease of technical implementation, or impacts current workflows (short term and long term). The greatest implementation challenge for this Use Case is to communicate the availability of its capability to providers and to compel them to participate and begin sending CQMs. This is due, at least in part, to the fact that many EHR vendors have not yet created the infrastructure to produce certified QRDA CAT 1 and QRDA CAT 3 files. Another challenge is converting individual QRDA CAT 1 files aggregate QRDA CAT 3 files, which is technically very difficult due to the extreme complexities of the measures, files, and different measure years. The infrastructure to convert QRDA CAT 1 to QRDA CAT 3 only began to appear in the middle of 2014 but is maturing rapidly. A significant portion of the effort for this Use Case has been applied to advancing the CAT 1 to CAT 3 conversion infrastructure. Other challenges include delays caused by the industry not having good test data in large quantities. This has been addressed by creating a Patient Generator that produces unlimited quantities of realistic but synthetic (i.e. non PHI) QRDA files for any zip code in the U.S. MiHIN has generated hundreds of thousands of test records, primarily QRDA CAT 1 files with fake patient names, for CMS, for several HIEs, and for the HIMSS Patient matching Connectathon in August, 2015. Other test decks containing synthetic patient information are being prepared for other states along with a general ability for organizations to request test data sets. MiHIN can now generate a wide variety of test decks for any organization, region, or state, and the test decks can have custom configured demographics and percentages of episodes of healthcare. For more information on the Patient Generator visit https://ehrintelligence.com/news/health information exchange focus of patient matching event and http://mihin.org/wp content/uploads/2015/08/himss Connectathon v2 08 24 15.pptx. Vendor Community Preparedness In this section, address the vendor community preparedness to readily participate in the implementation of this UC. Speak to whether this UC will utilize current or future technical capabilities of the vendor products. If this UC requires new functionality at the vendor level provide information as known to the timeliness of when product updates may be available and any potential costs to the HIE community. Many EHR vendors cannot yet calculate QRDA CAT 3 files. MiHIN is prepared to receive QRDA CAT 1 files and calculate QRDA CAT 3 files from the QRDA CAT 1 files so that the EHRs do not have to perform that complex work. 9

10

Support Information In this section, provide known information on the support for this UC. Support can come from multiple levels (Governor, Federal or State Legislative, MI HIT Commission, Michigan State Departments, CMS/ONC/CDC, MiHIN Board, Qualified Organizations, Payer Community, Interest Group [ex: MSMS, MHA], or Citizen support). Please note any concerns or oppositions with the Use Case Political Support: Governor Michigan Legislature HIT Commission MDHHS or other SOM Department CMS/ONC CDC MiHIN Board Other: Numerous organizations involved in national efforts to transform healthcare to be based on quality have reviewed and supported this effort approach to this Use Case including but not limited to: National Quality Forum National Committee for Quality Assurance Michigan Peer Review Organization (the Quality Improvement Organization (QIO) for Michigan Michigan State Medical Society Blue Cross Blue Shield of Michigan The MITRE Corporation s Medicaid Information Technology Architecture (MITA) team Concerns/Oppositions: None noted Sponsor(s) of Use Case Who are the major sponsors of the use case? Michigan Department of Health and Human Services MiHIN 11

Metrics of Use Case In this section, define metrics for the Use Case to be successful. The first key metric tracks the number of EHs, EPs and CAHs that enroll and participate in the electronic transmission of CQMs through MiHIN. The second metric is the frequency and quantity of CQM data submissions by providers and hospitals. The third metric is the utilization of the Data Mart to view CQMs by providers and payer organizations. The fourth metric is trend analysis of clinical quality improvements, resulting from usage of CQMs that lead to clear improvement trends as viewed across populations over time. The fifth metric is reduction of duplicate or similar measures being captured by Medicaid health plans or similar entities from alternative non standard processes. Other metrics will be identified. Other Information This section is to afford the sponsor(s) an opportunity to address any additional information with regard to this UC that may be pertinent to assessing its potential impact. 12